Duloxetine vs Pembrolizumab

## Duloxetine vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between **Duloxetine** and **Pembrolizumab**.

## Mechanism of Action

**Duloxetine**: Serotonin-norepinephrine reuptake inhibitor (SNRI).

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

## Pharmacokinetics

**Half-life**: Duloxetine — 12 hours; Pembrolizumab — 26 days.

## Chemical Properties

**Molecular Formula**: Duloxetine — C18H19NOS; Pembrolizumab — N/A.

**Molecular Weight**: Duloxetine — 297.4150 g/mol; Pembrolizumab — N/A.

**Type**: Duloxetine — Small molecule; Pembrolizumab — Antibody.